Axon Therapeutics
San Diego, US · Founded 2022
Biotech
Founders & leadership
DC
David c DodickDirector
PR
Pierre RiviereExecutive Officer, Director
FP
Frank PorrecaDirector
Reported raises · per SEC filings
Form D private placements▶$5MraisedAug 2022 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedAug 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David c DodickDirector
- Pierre RiviereExecutive Officer, Director
- Frank PorrecaDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.